ConductScience.org, home

Paper3965588

Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations.

Bayer AS and 1 other. J Infect Dis, 1985. Cited by 93 papers, by iCite.

Cite this record

ConductScience Library. Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations. Papers, record 3965588. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3965588

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations.
PubMed
Journal
J Infect Dis
PubMed
Year
1985
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
93
iCite
Relative citation ratio, by iCite
4.25
iCite
Revised in PubMed
2019-05-11
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bayer ASA S
2Lam KK

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Endocarditis, BacterialMajor topic
RifampinMajor topic
Staphylococcal InfectionsMajor topic
VancomycinMajor topic
Animals
Creatinine
Disease Models, Animal
Drug Therapy, Combination
Kidney
Methicillin
Microbial Sensitivity Tests
Penicillin Resistance
Rabbits
Staphylococcus aureus

Source PubMed

Download CSV of topics

Cited by37

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 93 citations.

PMIDTitleJournalYearIn PapersSource
37887720The In Vitro Antimicrobial Susceptibility of Borrelia burgdorferi sensu lato: Shedding Light on the Known Unknowns.Pathogens2023https://conductscience.org/library/papers/37887720PubMed
35129409Investigational agents for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: progress in clinical trials.Expert Opin Investig Drugs2022https://conductscience.org/library/papers/35129409PubMed
34223108Open wounds and rifampicin therapy are associated with rifampicin resistance among staphylococcal vascular graft/endograft infections.JAC Antimicrob Resist2021https://conductscience.org/library/papers/34223108PubMed
34097491Efficacy of Antistaphylococcal Lysin LSVT-1701 in Combination with Daptomycin in Experimental Left-Sided Infective Endocarditis Due to Methicillin-Resistant Staphylococcus aureus.Antimicrob Agents Chemother2021https://conductscience.org/library/papers/34097491PubMed
32191760Adjunctive rifampin for the treatment of Staphylococcus aureus bacteremia with deep infections: A meta-analysis.PLoS One2020https://conductscience.org/library/papers/32191760PubMed
24775563Factors predictive of treatment failure in staphylococcal prosthetic vascular graft infections: a prospective observational cohort study: impact of rifampin.BMC Infect Dis2014https://conductscience.org/library/papers/24775563PubMed
22553438Influence of rifampin therapy on serum bactericidal activity in the presence of cloxacillin and vancomycin.Can J Infect Dis1990https://conductscience.org/library/papers/22553438PubMed
21859940Efficacy of NZ2114, a novel plectasin-derived cationic antimicrobial peptide antibiotic, in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.Antimicrob Agents Chemother2011https://conductscience.org/library/papers/21859940PubMed
20065324Rifampin combination therapy for nonmycobacterial infections.Clin Microbiol Rev2010https://conductscience.org/library/papers/20065324PubMed
19072553Role of mgrA and sarA in methicillin-resistant Staphylococcus aureus autolysis and resistance to cell wall-active antibiotics.J Infect Dis2009https://conductscience.org/library/papers/19072553PubMed
17712583Rifampin as adjuvant treatment of Gram-positive bacterial infections: a systematic review of comparative clinical trials.Eur J Clin Microbiol Infect Dis2007https://conductscience.org/library/papers/17712583PubMed
15388469In vitro killing of community-associated methicillin-resistant Staphylococcus aureus with drug combinations.Antimicrob Agents Chemother2004https://conductscience.org/library/papers/15388469PubMed
14506020Rapid direct method for monitoring antibiotics in a mouse model of bacterial biofilm infection.Antimicrob Agents Chemother2003https://conductscience.org/library/papers/14506020PubMed
12937013Efficacy of linezolid alone or in combination with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.Antimicrob Agents Chemother2003https://conductscience.org/library/papers/12937013PubMed
12878535Efficacy of linezolid plus rifampin in an experimental model of methicillin-susceptible Staphylococcus aureus endocarditis.Antimicrob Agents Chemother2003https://conductscience.org/library/papers/12878535PubMed
11959588Comparison of levofloxacin, alatrofloxacin, and vancomycin for prophylaxis and treatment of experimental foreign-body-associated infection by methicillin-resistant Staphylococcus aureus.Antimicrob Agents Chemother2002https://conductscience.org/library/papers/11959588PubMed
11257041
Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics.
Antimicrob Agents Chemother2001https://conductscience.org/library/papers/11257041PubMed
10508047Treatment of experimental staphylococcal endocarditis due to a strain with reduced susceptibility in vitro to vancomycin: efficacy of ampicillin-sulbactam.Antimicrob Agents Chemother1999https://conductscience.org/library/papers/10508047PubMed
9624475Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis.Antimicrob Agents Chemother1998https://conductscience.org/library/papers/9624475PubMed
9360059Recognition, management and prophylaxis of endocarditis.Drugs1997https://conductscience.org/library/papers/9360059PubMed

See all 37 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3965588

GET https://conductscience.org/api/papers/v1/3965588/cited_by?page=2